siRNA Library Screening for Pharmacologic Radiation Mitigators
siRNA Library Screening for Pharmacologic Radiation Mitigators
批准号:
8382544
负责人:
JOHN S. LAZO
金额:
$39.58万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdoptedAnimal ModelApoptosisBCL2 geneBiological AssayBiological MarkersCardiolipinsCell Culture TechniquesCellsCollaborationsComplexComputer AnalysisComputing MethodologiesDevelopmentDrug Delivery SystemsDrug KineticsDrug usageEnsureExposure toGeneral PopulationGenomeGlyburideHumanLeadLinkMitochondriaMolecular TargetNew AgentsNitric Oxide SynthaseNuclearOleic AcidsOxidoreductasePathway interactionsPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyProteinsRNARNA InterferenceRNA libraryRadiationRadiation ToxicityRadioactiveResourcesScreening procedureSentinelStabilizing AgentsStandardizationStructureSystemTissuesToxic effectWaranalogcombatdesigndrug discoveryinhibitor/antagonistinnovationirradiationnanoparticlenitrationnovelprogramssmall moleculesmall molecule libraries
中文摘要
电离辐射诱导细胞中的RNA,这些RNA可以在辐射前被siRNA靶向以识别新的
辐射防护药物的靶标。我们已经成功地使用这一策略来识别一种常见的药物,
格列本脲作为一种新型的辐射防护剂。我们现在建议应用这一策略来确定辐射缓释剂
药物利用辐射敏感的人体细胞靶点和siRNA在照射后进行筛选。1**具体目标是
优化和部署用于检测新缓解药物的RNA靶标的哨兵细胞。第二个目标将是
使用可药物siRNA文库和小分子文库来鉴定辐射损伤缓释剂。这个
第三个目标将是确定与优先药物积极互动的目标,以促进辐射缓解
效果。
英文摘要
Ionizing irradiation induces RNAs in cells which can be targeted prior to irradiation by siRNA to identify novel
targets for radioprotector drugs. We have successfully used this strategy to identify a co,mmon drug,
Glyburide, as a novel radioprotector. We now propose to apply this strategy to identify radiation mitigator
drugs using radiosensitive human cell targets and siRNA screening after irradiation. The 1** Specific Aim will
optimize and deploy sentinel cells for detecting RNA targets for new mitigator drugs. The second aim will be
to use druggable siRNA libraries and small molecule libraries to identify radiation damage mitigators. The
third aim will be to identify targets that interact positively with prioritized drugs to advance radiation mitigation
effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10632154
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2022
-
负责人:JOHN S. LAZO
-
依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10330408
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2021
-
负责人:JOHN S. LAZO
-
依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10540550
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2021
-
负责人:JOHN S. LAZO
-
依托单位:
Developing small molecule PTP4A3 inhibitors for ovarian cancer
-
批准号:9769367
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2019
-
负责人:JOHN S. LAZO
-
依托单位:
Operetta CLS High-content Imaging System
-
批准号:9274679
-
项目类别:
-
资助金额:$51.6万
-
财政年份:2017
-
负责人:JOHN S. LAZO
-
依托单位:
PTP4A3 as a Molecular Cancer Target
-
批准号:8814295
-
项目类别:
-
资助金额:$20.42万
-
财政年份:2014
-
负责人:JOHN S. LAZO
-
依托单位:
CHEMICAL BIOLOGY FACILITY
-
批准号:8181010
-
项目类别:
-
资助金额:$9.53万
-
财政年份:2010
-
负责人:JOHN S. LAZO
-
依托单位:
siRNA Library Screening for Pharmacologic Radiation Mitigators
-
批准号:8010798
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2010
-
负责人:JOHN S. LAZO
-
依托单位:
Chemical Complementation Assay for MKP-3 (RMI)
-
批准号:7057143
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
In Vitro High Throughput Screening Assay for MKP-3(RMI)
-
批准号:7058166
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7076269
-
项目类别:
-
资助金额:$334.7万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7691436
-
项目类别:
-
资助金额:$75.75万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7231271
-
项目类别:
-
资助金额:$1.99万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
In Vitro High Throughput Screening Assay for MKP-1(RMI)
-
批准号:7058173
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7277157
-
项目类别:
-
资助金额:$372.19万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7502274
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Core--Medicinal chemistry: discovery and screening
-
批准号:7055205
-
项目类别:
-
资助金额:$18.42万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
CANCER STRESS RELEVANT PROTEIN PHOSPHATASE TARGETS
-
批准号:6923496
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Chemical Complementation Assay for MKP-1 (RMI)
-
批准号:7058509
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
MOLECULAR PHARM. AND BIOCHEM. OF NOVEL DUAL SPECIIFICITY PHOSPHATASE INHIBITORS
-
批准号:6928832
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
海外基金